A detailed history of Advisor Partners Ii, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 1,339 shares of UTHR stock, worth $426,538. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,339
Previous 1,243 7.72%
Holding current value
$426,538
Previous $274,000 10.22%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$211.82 - $248.24 $20,334 - $23,831
96 Added 7.72%
1,339 $302,000
Q2 2023

Aug 10, 2023

BUY
$205.19 - $232.99 $6,976 - $7,921
34 Added 2.81%
1,243 $274,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $6,815 - $8,837
32 Added 2.72%
1,209 $270,000
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $242,403 - $330,066
1,177 New
1,177 $327,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.